CVS Caremark Corp. has appointed Kevin Murphy as president of subsidiary Accordant Health Services.


CVS Caremark, Kevin Murphy, Accordant Health Services, president, Accordant president, Troy Brennan, rare disease management, medical pharmacy management, specialty pharmacy, disease management, case management services, rare chronic conditions








































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Retail News Breaks Archives

CVS Caremark names Accordant president

November 17th, 2011

WOONSOCKET, R.I. – CVS Caremark Corp. has appointed Kevin Murphy as president of subsidiary Accordant Health Services.

Accordant provides disease management and case management services for people with rare chronic conditions. CVS Caremark said Thursday that as Accordant's president, Murphy is charged with integrating the company's rare disease management programs with its specialty pharmacy programs and new focus on medical pharmacy management.

Murphy brings over 20 years of experience in marketing, strategy and product development to CVS Caremark, the company noted. He joins CVS Caremark from Mercer, where he was a partner in the human resource consulting practice.

Previously, Murphy led the market, strategy and development organization of Accredo, Medco's specialty pharmacy division. While at Medco, as well as in a previous position with Physicians Health Services (PHS), he held various leadership roles in sales, marketing and product development, according to CVS Caremark.

"Kevin Murphy 's in-depth experience in specialty pharmacy, knowledge of the industry and strong client-management background make him uniquely qualified to lead the Accordant business," Troy Brennan, executive vice president and chief medical officer at CVS Caremark, said in a statement. "His expertise will enable us to further enhance our offerings focused on disease management for complex chronic diseases and identify innovative approaches to help these patients on their path to better health."

Advertisement